The Science Behind NanoCBD
Why Most CBD Doesn't Work — And How We Fixed It
Traditional CBD oil delivers as little as 4–6% of its active compounds to your bloodstream. Our scientifically developed NanoCBD formula delivers 20-50%. Here's the science.
Arkos Bioscience uses a proprietary mechanical process to reduce CBD particles from roughly 2,000 nanometers to under 100 nanometers, then encapsulates each particle to prevent re-clustering. This transforms CBD from a hydrophobic oil into a water-compatible compound that can pass through cellular membranes, achieving 3–8x higher bioavailability (European Journal of Pharmaceutics) than standard CBD formulations.
- Step 1: Mechanical particle reduction (~2,000nm → ~60nm)
- Step 2: Individual particle encapsulation (prevents re-clustering)
- Step 3: Water-compatibility transformation (enables absorption)
- Result: 20–50% bioavailability (Molecules) vs 4–8% for standard CBD
Arkos NanoCBD — Key Facts
- ✦ Particle size: Reduced from ~2,000nm to ~60nm
- ✦ Method: Mechanical reduction (not chemical emulsification)
- ✦ Encapsulation: Each particle individually wrapped to prevent re-clustering
- ✦ Result: Water-compatible CBD with 3–8x better absorption
- ✦ Bioavailability: 20–50% vs industry standard of 4–8%
- ✦ Formulated by: Yale PhD particle engineer
What Is CBD Bioavailability — and Why Does It Matter?
Bioavailability is the percentage of a substance that actually enters your bloodstream and produces an effect. When it comes to CBD, most products on the market have a serious bioavailability problem.
When you swallow a traditional CBD oil or capsule, it passes through your digestive system before reaching your bloodstream. Your liver breaks it down in what's called the "first-pass effect" — and by the time CBD reaches circulation, studies show only 4–20% of the original dose remains active.
"If you're taking 30mg of traditional CBD oil, your body may only be using 1–4mg of it. The rest is wasted — and so is your money."
This is why so many people say CBD "doesn't work" for them. It's not that CBD is ineffective — it's that the delivery method is failing them. This is the problem Arkos Bioscience was built to solve.
How CBD Delivery Methods Compare
Not all CBD products absorb equally. Here's how Arkos NanoCBD compares to every major CBD delivery format.
How NanoCBD Achieves 3-8x Better Absorption
The Science of NanoCBD
Our formula was developed by a PhD scientist specializing in pharmaceutical nano-engineering. Using a proprietary process, CBD molecules are broken down to less than 100 nanometers — smaller than your body's cellular membranes. At this scale, CBD can pass directly through cell walls without digestion.
Water-Soluble for Full-Body Absorption
Traditional CBD is oil-based — and your blood is water-based. Oil and water don't mix, which is why so much CBD gets rejected. Our nano-technology process makes CBD water-soluble, allowing it to integrate directly into your bloodstream with no rejection or first-pass loss.
Bypasses the Liver's First-Pass Effect
Because our particles are nano-sized and water-soluble, they're absorbed through the sublingual membrane and gut lining before they can be metabolized by the liver. This means the full dose reaches your endocannabinoid system — not a fraction of it.
Results in 15–30 Minutes, Not Hours
Higher bioavailability means faster onset. Most customers feel the effects of Arkos NanoCBD within 15–30 minutes, compared to 45–90 minutes for standard sublingual CBD and up to 2+ hours for capsules or edibles.
Arkos NanoCBD vs. Traditional CBD
Every spec that matters at a glance.
| ⬡ Arkos NanoCBD | Traditional CBD Oil | |
|---|---|---|
| Bioavailability | 20-50% | 4–20% |
| Particle Size | <100 nanometers | Large oil droplets |
| Water Soluble | ✓ | ✗ |
| Onset Time | 15–30 minutes | 45–120 minutes |
| Bypasses First-Pass Effect | ✓ | ✗ |
| Formulated by PhD Scientist | PhD-Formulated | Typically not |
| 3rd-Party Lab Tested | ✓ Every batch | Varies |
| THC-Free Guaranteed | ✓ | Varies |
| Cost Per Effective mg | Lower (more absorbed) | Higher (mostly wasted) |
Frequently Asked Questions About CBD Bioavailability
How Arkos NanoCBD Works
Our proprietary nano-emulsion technology breaks CBD into particles 30× smaller than traditional oils, encapsulates each one, and delivers them directly into your bloodstream.
Traditional CBD vs. Arkos NanoCBD
Visualized Science
The Science, Visualized
These diagrams illustrate why particle size is everything in CBD delivery.
Traditional CBD clusters (~2,000nm) cannot penetrate the skin barrier. Arkos NanoCBD particles (under 100nm) pass directly through.
At ~60nm, Arkos NanoCBD particles are smaller than skin barrier pores (55–100nm), enabling direct passage into the body.
Explore the Science
Experience the Difference
Stop wasting money on CBD that your body can't absorb. Arkos NanoCBD is the most bioavailable CBD formula available — backed by PhD-level science, verified by independent labs, and guaranteed to perform.
Shop NanoCBD Our Bestseller →*Bioavailability figures based on published pharmacokinetic research comparing nano-CBD vs. conventional cannabinoid delivery systems. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
Sources
- National Center for Biotechnology Information — Cannabidiol pharmacokinetics and absorption
- Frontiers in Nutrition — Oral CBD bioavailability research
- Molecules (journal) — Nanoemulsion delivery systems for cannabinoids
- European Journal of Pharmaceutics and Biopharmaceutics — Drug bioavailability and nanoformulations
Related Reading
CBD Bioavailability: What the Research Actually Says — peer-reviewed evidence, comparison tables, and honest numbers.
>